摘要 |
Disclosed are glucagon-like peptide-1 (GLP-1) compounds with modifications at one or more of the following positions: 11, 12, 16, 22, 23, 24, 25, 27, 30, 33, 34, 35, 36, or 37. Methods of treating these GLP-1 compounds are also disclosed. |
申请人 |
ELI LILLY AND COMPANY;GLAESNER, WOLFGANG;MILLICAN, ROHN, LEE |
发明人 |
GLAESNER, WOLFGANG;MILLICAN, ROHN, LEE |